Immunovant Q3 Earnings Assessment

Immunovant (NASDAQ:IMVT) announced its Q3 earnings on Friday, February 6, 2026 at 07:00 AM.

Here's a breakdown of the earnings report.

Earnings

Immunovant beat estimated earnings by 14.08%, reporting an EPS of $-0.61 versus an estimate of $-0.71.

Revenue was down $0 from the same period last year.

Previous Earnings Records

Last quarter the company missed on EPS by $0.01 which was followed by a 2.05% drop in the share price the next day.

To track all earnings releases for Immunovant visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.